Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from JMP Securities

Meta Platforms To $200? These Analysts Slash Price Targets On Meta Following Q3 Results

Meta Platforms, Inc. (NASDAQ: META) reported worse-than-expected Q3 EPS and issued Q4 revenue guidance with a midpoint below estimates. The company also guided FY23 expenses of $96 billion to $101 billion. Meta Platforms shares dropped 22.1% to $101.20 on Thursday.

Benzinga

Alphabet To $145? These Analysts Cut Price Targets On Alphabet After Downbeat Q3 Results

Alphabet Inc. (NASDAQ: GOOGL) reported weaker-than-expected earnings results for its third quarter after the closing bell on Tuesday.

Benzinga

Zoom Had Disappointing Quarter, Faces Transition Year: Here's Why Some Analysts Are Cutting Price Targets

Video communications company Zoom Video Communications Inc (NASDAQ: ZM) reported earnings per share (EPS) that beat Street estimates and revenue which missed Street estimates on Monday. Analysts sized up the latest quarterly report and the company’s guidance.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

EBay "Thesis Not Changing" Analysts Say After Strong Guidance, Mixed Earnings

Analysts are sizing up the second-quarter financial report from marketplace and auction company eBay Inc (NASDAQ: EBAY), which reported results Wednesday after market close. The eBay Analysts: Needham analyst Anna Andreeva had a Hold rating and no price target.

Benzinga

Lock In High Dividend Yields While Prices Are Still Down On These 7 REITs

It’s entirely possible to receive much higher dividend yields on certain real estate investment trusts (REITs) than on the 10-year Treasury Note rate right now if you’re willing to accept more risk. In alphabetical order, these six real estate investment trusts pay big dividends:

Benzinga

Analysts Remain Cautious Over SAP Post Q2 Results

Analysts remained divided with a cautious tone over SAP SE's (NYSE:SAP) prospects post Q2 results. Barclays analyst Raimo Lenschow saw SAP managing expectations into Q2, and the move lower in consensus halved the adj. EBIT miss. He found the FY guidance cut was unexpected, though, especially following reiterations in the quarter, and could not…

Benzinga

What's Going On With Shopify Stock?

Shopify Inc (NYSE: SHOP) shares are trading higher Tuesday amid a drop in yields.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Read JMP Securities Analyst's Take On Shopify

JMP Securities analyst Andrew Boone initiated coverage on Shopify Inc (NYSE:SHOP) with a Market Perform rating. Shopify is a leading commerce platform that entered a significant investment cycle as it offers fulfillment services to merchants, which he believed will limit margin expansion and free cash flow generation. He believed Shopify offered a best-in-class commerce service and expected…

Benzinga

JMP Securities Maintains Market Outperform Rating for Snap: Here's What You Need To Know

JMP Securities has decided to maintain its Market Outperform rating of Snap (NYSE:SNAP) and lower its price target from $45.00 to $42.00. Shares of Snap are trading down 5.52% over the last 24 hours, at $13.19 per share. A move to $42.00 would account for a 218.42% increase from the…

Benzinga

Why MGM Resorts Stock Is Trading Higher Today

MGM Resorts International (NYSE: MGM) shares are trading higher Tuesday following bullish analyst coverage from JMP Securities.

Benzinga

Not All Cloud Cloud Companies Are Equal: 4 Analysts Cautious On Oracle After Q4, Here's Why

Shares of Oracle Corporation (NYSE: ORCL) are trading higher Tuesday after the company reported fourth-quarter earnings results after market close Monday.

Benzinga

Here's How Analysts View Braze Post Q1 Beat

Analysts acknowledged Braze, Inc's (NASDAQ:BRZE) Q1 beat amid macro headwinds. Piper Sandler analyst Brent Bracelin maintained Braze with an Overweight and cut the price target from $65 to $42 based on lower growth assumptions given increasing external risks. Despite increasing macro headwinds, BRZE delivered another strong quarter. Increasing investments in direct-to-consumer (DTC) and first-party data stacks have…

Benzinga

JMP Securities Maintains Market Outperform Rating for DocuSign: Here's What You Need To Know

JMP Securities has decided to maintain its Market Outperform rating of DocuSign (NASDAQ:DOCU) and lower its price target from $180.00 to $151.00. Shares of DocuSign are trading down 24.11% over the last 24 hours, at $66.30 per share.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022

Upgrades

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022

Upgrades

Benzinga

JMP Securities Maintains Market Outperform Rating for Goosehead Insurance: Here's What You Need To Know

JMP Securities has decided to maintain its Market Outperform rating of Goosehead Insurance (NASDAQ:GSHD) and lower its price target from $140.00 to $130.00. Shares of Goosehead Insurance are trading up 5.59% over the last 24 hours, at $55.66 per share.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Sprinklr Shares Gain As Analysts Hail Its Q4

Analysts mostly lifted their price targets on Sprinklr Inc (NYSE:CXM) following its Q4 beat. Sprinklr clocked Q4 FY21 revenue growth of 30% year-over-year to $135 million, beating the consensus of $130.38 million. Subscription revenue increased by 30.7% Y/Y to $117.69 million. "We accelerated our growth, went public, and created a new category called…

Benzinga

Crinetics' CRN04777 Shows Dose-Dependent Suppression of Fasting Insulin

Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) announced topline results from the multiple ascending dose (MAD) cohorts of healthy volunteers in the Phase 1 study of CRN04777. CRN04777 is a nonpeptide somatostatin receptor type 5 (SST5) agonist as an oral treatment for congenital monogenic and syndromic hyperinsulinism. This condition causes individuals to have abnormally high insulin…

Benzinga

Read Why JMP Securities Lowered Price Target On Rover Group

JMP Securities analyst Ronald Josey lowered the price target on Rover Group Inc (NASDAQ:ROVR) to $11 (131% upside) from $15 and kept an Outperform rating on the shares post Q4 results. The analyst stated that omicron has increased cancellation rates in Q4 and impacted demand in Q1, limiting revenue visibility for 2022. In the longer…

Benzinga

Why Are Upwork Shares Trading Lower Today?

JMP Securities analyst Andrew Boone lowered the price target on Upwork Inc (NASDAQ:UPWK) to $48 from $55 and maintained an Outperform rating on the shares after its in-line Q4 earnings and below-consensus outlook. The analyst mentions that the company is making substantial investments in the business while delaying profitability, now estimating 2022 EBITDA to be…

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.